BFEC
LLY icon

Benjamin F. Edwards & Company’s Eli Lilly LLY Stock Holding History

Benjamin F. Edwards & Company’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		$7.9M Buy
8,723
+276
+3% +$221K 0.14% 165
2024
Q1 		$6.57M Buy
8,447
+153
+2% +$109K 0.12% 185
2023
Q4 		$4.83M Buy
8,294
+2,746
+49% +$1.6M 0.1% 206
2023
Q3 		$2.98M Buy
5,548
+1,068
+24% +$550K 0.11% 176
2023
Q2 		$2.1M Sell
4,480
-35
-0.8% -$14.7K 0.08% 231
2023
Q1 		$1.55M Buy
4,515
+1,111
+33% +$375K 0.06% 258
2022
Q4 		$1.25M Buy
3,404
+24
+0.7% +$8.51K 0.06% 299
2022
Q3 		$1.09M Buy
3,380
+16
+0.5% +$5.07K 0.05% 300
2022
Q2 		$1.09M Hold
3,364
– – 0.05% 310
2022
Q1 		$963K Sell
3,364
-416
-11% -$107K 0.04% 349
2021
Q4 		$1.04M Sell
3,780
-41
-1% -$10.4K 0.05% 342
2021
Q3 		$883K Buy
3,821
+219
+6% +$54.1K 0.04% 355
2021
Q2 		$827K Sell
3,602
-332
-8% -$66.7K 0.04% 361
2021
Q1 		$735K Buy
3,934
+229
+6% +$44.8K 0.04% 384
2020
Q4 		$626K Sell
3,705
-271
-7% -$40.5K 0.04% 388
2020
Q3 		$589K Sell
3,976
-380
-9% -$58.8K 0.04% 363
2020
Q2 		$715K Buy
4,356
+444
+11% +$68.2K 0.05% 310
2020
Q1 		$543K Sell
3,912
-463
-11% -$63.6K 0.05% 320
2019
Q4 		$575K Buy
4,375
+401
+10% +$46.5K 0.04% 353
2019
Q3 		$444K Sell
3,974
-4,100
-51% -$456K 0.03% 386
2019
Q2 		$894K Sell
8,074
-73
-0.9% -$8.6K 0.08% 256
2019
Q1 		$1.06M Sell
8,147
-495
-6% -$60.2K 0.1% 225
2018
Q4 		$1M Buy
8,642
+1
+0% +$112 0.1% 211
2018
Q3 		$927K Buy
8,641
+1,546
+22% +$155K 0.09% 238
2018
Q2 		$605K Sell
7,095
-1,010
-12% -$83K 0.06% 292
2018
Q1 		$627K Sell
8,105
-216
-3% -$17.4K 0.06% 286
2017
Q4 		$703K Buy
8,321
+976
+13% +$83K 0.07% 266
2017
Q3 		$628K Sell
7,345
-433
-6% -$35.5K 0.08% 249
2017
Q2 		$640K Buy
7,778
+151
+2% +$12.3K 0.08% 239
2017
Q1 		$641K Sell
7,627
-266
-3% -$21.3K 0.09% 224
2016
Q4 		$581K Buy
7,893
+325
+4% +$24.2K 0.1% 227
2016
Q3 		$607K Buy
7,568
+4,263
+129% +$341K 0.11% 201
2016
Q2 		$260K Buy
3,305
+31
+0.9% +$2.33K 0.05% 285
2016
Q1 		$236K Buy
3,274
+169
+5% +$12.8K 0.05% 283
2015
Q4 		$262K Sell
3,105
-27
-0.9% -$2.24K 0.06% 274
2015
Q3 		$262K Sell
3,132
-140
-4% -$11.8K 0.06% 270
2015
Q2 		$273K Buy
3,272
+25
+0.8% +$1.91K 0.05% 296
2015
Q1 		$236K Buy
3,247
+1,354
+72% +$96.4K 0.05% 306
2014
Q4 		$131K Hold
1,893
– – 0.03% 356
2014
Q3 		$123K Buy
1,893
+50
+3% +$3.17K 0.03% 374
2014
Q2 		$115K Hold
1,843
– – 0.03% 362
2014
Q1 		$108K Sell
1,843
-600
-25% -$33.5K 0.03% 357
2013
Q4 		$125K Buy
2,443
+806
+49% +$40.4K 0.04% 310
2013
Q3 		$82K Sell
1,637
-11,556
-88% -$605K 0.03% 332
2013
Q2 		$648K Buy
+13,193
New +$718K 0.26% 104

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Benjamin F. Edwards & Company's LLY Position: Q2 2024 in Review

Benjamin F. Edwards & Company increased its Eli Lilly (LLY) stake by 3.3% in Q2 2024, buying an estimated $221K and bringing the position to 8,723 shares worth $7.9M. The position accounts for 0.14% of the portfolio, ranked #165.

Benjamin F. Edwards & Company first reported a position in LLY in Q2 2013 and has held it in 45 quarters since. 3,565 funds tracked by Wall St. Rank hold LLY as of Q2 2024.

  • Benjamin F. Edwards & Company held 8,723 shares of Eli Lilly worth $7.9M as of Q2 2024.
  • Benjamin F. Edwards & Company bought 276 Eli Lilly shares in Q2 2024, an estimated $221K.
  • Eli Lilly made up 0.14% of Benjamin F. Edwards & Company's portfolio in Q2 2024, its #165 holding.
  • Benjamin F. Edwards & Company first reported a position in Eli Lilly in Q2 2013 and has held it in 45 quarters since.
  • 3,565 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2024.

Based on Benjamin F. Edwards & Company's 13F filing for Q2 2024, filed 12 Aug 2024.